The effect of gender, age, and geographical location on the incidence and prevalence of renal replacement therapy in Wales
© van Woerden et al; licensee BioMed Central Ltd. 2007
Received: 19 April 2006
Accepted: 11 January 2007
Published: 11 January 2007
This study used a cross sectional survey to examine the effect of gender, age, and geographical location on the population prevalence of renal replacement therapy (RRT) provision in Wales.
Physicians in renal centres in Wales and in adjacent areas of England were asked to undertake a census of patients on renal replacement therapy on 30 June 2004 using an agreed protocol. Data were collated and analysed in anonymous form.
2434 patients were on RRT in Wales at the census date. Median age of patients on RRT was 56 years, peritoneal dialysis 58 years, haemodialysis 66 years and transplantation 50 years. The three treatment modalities had significantly different age-specific peak prevalence rates and distributions. RRT age-specific prevalence rates peaked at around 70 years (1790 pmp), transplantation at around 60 years (924 pmp), haemodialysis at around 80 years (1080 pmp) and peritoneal dialysis did not have a clear peak prevalence rate. Age-specific incidence of RRT peaked at a rate of 488 pmp at 79 years, as did incidence rates for haemodialysis, which peaked at the same age. Age had less effect on the initiation of peritoneal dialysis, which had a broad plateau between the early fifties and late seventies. Kidney transplantation rates were highest in the early fifties but were markedly absent in old age.
Differences in the provision of RRT are evident, particularly in the very elderly, where the gender difference for haemodialysis is particularly marked. The study illustrates that grouping patients over 75 years into a single age-band may mask significant diversity within this age group. Significant numbers of very elderly patients who are currently not receiving RRT may wish to receive RRT as the elderly population increases, and as technology improves survival and quality of life on RRT.
The study suggests that if technologies that are more effective were developed, and which had a lower impact on quality of life, there might be up to a 17% increase in demand for RRT in those aged over 75 years; around 90% of this increased demand would be for haemodialysis.
Since the introduction of renal replacement therapy (RRT) in the UK in 1946 , its use has risen steadily. As survival has improved, there has been an increasing willingness to offer dialysis to a wider range of patients including older patients. This has resulted in rising annual incidence (acceptance) and prevalence rates. In the 1960s, dialysis was rarely offered to patients over 65 years. The acceptance rate for RRT has steadily risen from around 22 per million population (pmp)  in the UK population in 1982, to 133 pmp in Wales in 2003 . The prevalence rate has also risen, in England and Wales, from around 393 pmp  in 1993 to over 700 pmp  in 2003. The continuing rise in demand for RRT has imposed a huge strain on resources in renal services . There have been recurrent demands for yet more investment and some surprise that demand has not reached a plateau. Geographical boundaries in Wales have changed and there was concern to ensure that further investment addressed, rather than increased, inequalities in gender, age and geographical location. Some concern had also been expressed regarding the reliability and independence of available data. This study attempted to address and explain some of the issues behind the ongoing requirement for further investment.
A number of factors underlie the rising demand in RRT. Technological advances have encouraged the offering of RRT to older patients with greater co-morbidity. Technological advances have also improved survival, increasing the incidence and prevalence of patients on RRT. A rapidly aging population, has, and will increasingly, exacerbate the effect of the above factors, as population predictions suggest that the number of people aged over 60 years will rise by around 65 per cent over the next 50 years. Similarly, the number of people aged over 75 years is expected to double, and the number of people aged 90 years and over is expected to more than triple .
Separate analysis of data on RRT prevalence or incidence in the very elderly has historically been scarce and the use of summary measures of RRT, encompassing wide age bands, may also have obscured the underlying shifts in the numerators and denominators in the elderly. This study has consequently used age-specific rates, which have a number of advantages over age-standardised rates as they are unaffected by differences in demography . This allows the separating out of age related factors and factors associated with changes in the provision (demand and supply) of RRT. Age-standardised rates can only be compared with other age-standardised rates using the same age-standardised population. For example, age-standardised rates for the UK population cannot be compared with age-standardised rates for the European population or the North American population. In contrast, age specific rates can be compared between any two populations without being affected by different population pyramids in the different populations [10, 11].
Age-specific rates have advantages over age-standardised rates, particularly for the oldest age band in any analysis. For example, two identical age-standardised rates for individuals "over 75 years" could represent two very different populations. One population where all the population in this age-band were aged 75–80 years (i.e. had died by the age of 80 years) and another population where there were a large proportion of patients living on to 90–100 years and over. Detailed differences within the age-band "over 75 years" are very relevant to the cost of providing RRT, given the demographic shift occurring in the western world. The cost of a patient aged 100 years on RRT is likely to differ from the cost of treating a patient aged 75 years because of general frailty and co-morbidity.
A doubling of the number of patients on RRT over, say 80 years or over 90 years will have a major impact on service provision as these patients are frail and have multiple co-morbidities. However, because the very elderly make up only a small proportion of the population, such a rise in RRT would only result in a small rise in the overall age-standardised RRT rate for "the over 75 years". The additional workload for the service is consequently masked. The similar generation of age-specific rates in other countries or populations would facilitate debate on the emerging question as to the true level of unmet need for RRT in the ninth and tenth decades of life.
Other potential inequalities in RRT provision are also important to consider. This study has therefore examined the effect of gender, geographical location and modality of RRT on RRT prevalence rates. Insufficient numbers were available to assess the effect of these factors on incidence rates.
A census of all patients in Wales on RRT was undertaken on 30 June 2004. This date was chosen, as it is the middle day of the year and population projections are calculated for that day of the year. A protocol was developed with input from renal physicians and circulated to previously agreed contacts in all renal centres in Wales and those in neighbouring areas in England used to treat Welsh patients. Data gathered included modality of RRT on that date, postcode, date of birth, gender and an indicator of whether the patient had first started RRT on or after 1 July 2003.
To comply with data protection legislation, no names or other personal identifiers were collected. The data were cleaned by comparing all postcodes with a database of all current and past postcodes in Wales and then removing patients with non-Welsh postcodes. Patients with missing or invalid postcodes or dates of birth were checked with the provider Trust. Data sets were combined in a secure Microsoft Sequel Server 2000 database. Duplicate entries were identified as those where the date of birth, gender and postcode were identical. The number of deceased patients in the collated data set was estimated to ensure that "ghost" patients would not unduly inflate our RRT rates.
The study was conducted in conformity with the requirements of the Declaration of Helsinki. Advice was sought from relevant experts to ensure compliance with Data Protection requirements. The South Wales Renal Managed Clinical Network determined that formal ethical approval was not required, as identifiable data was only made available to Health Solutions Wales staff, who have authorisation from the Patient Information Advisory Group (PIAG) to handle Patient Episode Database Wales (PEDW) data under Section 60 of the Health and Social Care Act 2001. This view was supported by Health Commission Wales, an executive agency of the Welsh Assembly Government, who commissioned the study.
To clean the data set further, possible entries representing deceased patients were identified by comparing date of birth, gender and postcode in our data set against the Welsh NHS Administrative Register (AR) held by Health Solution Wales. This comparison was made separately for patients treated by Welsh NHS Trusts and for one English Trust where there was concern that there might be a significant number of deceased patients. However, entries potentially representing deceased patients could not be removed from the dataset as the matching process could suggest, but not confirm, that a particular matching entry might represent a deceased patient. Our methodology was designed to estimate the potential size of this problem without having access to NHS numbers and to determine whether the numbers involved were sufficiently small as to be ignored in our calculation of RRT rates.
Denominator data were obtained from mid-year estimates of the population of Wales in 2004 (by Local Health Board) calculated by the Office of National Statistics for each one-year age band from the age of one to 89 years. For the one-year age bands between 90 and 99 years data from the 2001 census was used, as mid-year estimates are not available for ages over 89 years. No patients with an age of over 100 years were identified in the database and RRT rates for 100 years and over were consequently set to zero. Rates (pmp) were calculated for each one-year age band for the three modalities of RRT, i.e. haemodialysis, peritoneal dialysis and transplantation.
Moving averages of 3, 5, 7, 9, 11, 13 and 15 years were explored using an equal number of years above and below the age in question. An 11-year moving average was identified as providing the best balance between retention of definition of changing features of the graph, minimising lags in the peaks and troughs in the graph, and yet smoothing spikes in the data. Data for some graphs were truncated below 18 yrs and above 90 years because of numerators of fewer than 5 cases in some of the individual one-year age bands.
To indicate the probability of being on a given form of RRT at any given age, the proportion of patients on each of the three modalities of RRT was calculated for each one-year age band and converted into a percentage so that the three percentages came to 100%. An 11-year moving average was also applied to this data as described above. All data was analysed and graphed using Microsoft Excel™.
Postcodes were converted into a grid reference and recorded as an Easting and a Northing. Grid references were then mapped to Local Health Board (LHB) areas in Wales. This allowed the calculation of acceptance and prevalence rates by LHB. 95% confidence intervals were calculated for these rates using a SQL procedure which performs the confidence interval algorithm described by Newcombe and Wilson .
Summary measures for patients on RRT in Wales
Number of patients
Median age (years)
Mean age (years)
The result of our extensive data cleaning and validation exercise was as follows. The database contained 2434 records with unique dates of birth, which could also be fully matched to current or historical Welsh postcodes. An additional 167 records could not be matched to a Welsh LA area; 110 of these records clearly represented English postcodes; an additional 35 were probable English postcodes, and 22 records had invalid postcodes, which could potentially have been Welsh postcodes. The maximum number of missing Welsh records in our analysis would therefore be <1% (22/2434). In conclusion, the 167 unmatched and consequently excluded records identified during data validation largely represented English and not Welsh patients and their exclusion would consequently not have affected our analysis.
Comparison with the Welsh NHS AR indicated that only 10 records (0.45%) represented deceased patients that had not been removed from the renal registers in various NHS Trusts. A handful of patients may have been double counted as a result of errors in dates of birth or postcode changes. Detailed analysis also suggested that a handful of errors might also have occurred because patients moved house during the months preceding the census. Once again, our data validation indicated that these issues did not significantly affect our data.
A significant issue was identified in relation to one English NHS Trust. Comparison between NHS AR data and data on patients provided with a transplant by this Trust suggested around 3% of the patients still on the trust's renal register were deceased. These patients were removed from our database and consequently would not have affected our results. However, our data validation exercise indicated that other data collection exercises in the UK may have potentially significant errors due to inadequate removal of deceased patients from some trust renal registers.
This study demonstrates significant variation in the provision of RRT by gender, age, and geographical location. Differences in RRT rates were most marked by gender and age, and to a lesser extent by geographical location. Some of the gender difference in prevalence may be due to risk factors shared by cardiovascular disease and end stage renal failure, both of which are commoner in men. However, some of the gender differences in the very elderly, particularly the differences in haemodialysis, may be indicative of underlying inequality in treatment provision.
Implications for service provision can be drawn from the findings. Age-specific prevalence for peritoneal dialysis was relatively similar at all ages, and consequently, peritoneal dialysis services need to be designed to serve all age groups in the population. In contrast, support services for patients with renal transplants needs to be focused on those under 65 years. For example, attendance at outpatient clinics may significantly interfere with working age patients who have a transplant.
Patients in Wales under the age of 50 years have a greater than 50% chance of having a transplant (Figure 3), which is encouraging for younger patients waiting for a transplant.
The probability of being on peritoneal or haemodialysis varies depending on the LHB in Wales. This may represent the preferences of different clinicians for particular treatment modalities, and a wide range of socio-economic determinants, as well as random chance.
There are a number of possible reasons why the tertiary English NHS Trusts, which treat Welsh transplant patients, might have a higher number of patients recorded as being alive, when the NHS Administrative Register suggested that they were deceased. Firstly, there may be less accurate recording of death in this Trust. However, tertiary care centres may see patients less frequently, if joint care is undertaken with a locally based clinician. Consequently, if a patient dies in a local hospital, the tertiary centre may not be aware of the patient's demise. Our findings suggest that there is merit in linking databases held by different Trusts, in forming links between Trust databases, national renal databases and the NHS AR using patients NHS numbers. This would reduce inaccuracies around deceased patients, patients who have recently moved address, and patients attending multiple renal centres.
This study suggests that there may be a significant number of untreated elderly patients with end stage renal failure. Figure 1 indicates that the rate of RRT provision rises with age but falls after the mid-seventies. This is unexpected given the rising trend in morbidity up to this age. The true underlying rate of end stage renal failure is very unlikely to fall over the age of 75 years and this suggests that there may be a gap between need and supply in this very elderly age group. The discrepancy may be occurring because clinicians and patients are taking into account the personal, physical, social and psychological costs of treatment, and the very poor survival curves associated with current treatment over this age, and decide not to offer or accept RRT.
We can provide a crude estimate of the number of potentially untreated patients over the age of 75 years by linear extrapolation of the population rate for RRT from 1790 pmp at 75 years to 2500 pmp for the age group 100 years. Similarly, we can extrapolate the haemodialysis rate from 1000 pmp at 85 years to 1500 pmp at 100 years. Extrapolating in this way would suggest that an additional 442 individuals over the age of 75 years might wish to be treated, if RRT methods were developed that provided excellent rates of survival and low negative impact on patients' quality of life. This unmet "need" would represent a 17% increase on current demand for RRT.
These figures provide a crude estimate of the possible increase in future demand in the very elderly, without taking into account other factors such as demographic shift in the population, or increased provision of RRT to those under 75 years. In summary, these findings suggest that, as RRT technologies continue to improve, an increasing number of very elderly patients are likely to present for treatment.
Patients over the age of 75 years have a very high probability of being on haemodialysis. Population predictions for the next decade for Wales suggest that this population group will expand the most. Unless the current treatment pattern changes significantly, the high use of haemodialysis in old age (Figures 4 &5) combined with the demographic bulge predicted in this age group suggests that the demand for haemodialysis in the very elderly will continue to rise at a higher rate than in younger age groups.
Limitations of this study
Our study has a number of limitations. We have used a different method of calculating incidence from that used by the renal registry, which includes patients who started RRT in the year before the census date, but who also died in that year. Our figures would, therefore, be expected to indicate a lower rate than if these patients were included. Our incidence figures would have been improved if our data collection had included patients who died in the preceding year. Our data is cross-sectional: longitudinal data gives better estimates of incidence, although cross sectional studies such as ours, which ask for changes over the proceeding year, can be used.
A renal physician from every renal centre in Wales, and NHS Trusts in England that treat Welsh patients, was used as a point of contact. Data managers in each trust were also involved. As each trust keeps a database of patients receiving treatment for ESRF we were confident that all individuals receiving treatment had been identified. However, not all patients with ESRF present for treatment and not all patients with ESRF are offered or receive treatment. Prevalence estimates of ESRF based on treatment databases are consequently underestimates of the true prevalence.
Based on our discussion with renal physicians in Wales we are confident that we have identified all patients receiving treatment by a renal physician. However, very low acceptance rates reported in some areas (under 50 pmp) could theoretically be the result of local treatment and failure to refer by non-renal physicians.
Data on ethnicity was not collected in this study, as there are relatively low rates of non-white populations in most of Wales. However, this would have provided some useful additional information as end stage renal failure is affected by ethnic origin.
The peak rate for a given modality, shown in the graphs using a moving average, is around two to four years younger than the true value. This is because the moving average brings forward the peak in the graphs by between two to four years when calculated using a 'window' moving from left to right.
Co-morbidity was not assessed in this study; however, it is an important factor in the elderly. There is some evidence that the presence and severity of co-morbid conditions is more important than age as a predictor of survival after commencement of dialysis[14, 15]. Further information on the range, variation, severity and relative influence of co-morbidity on survival would have been informative.
Conservative options have also not been addressed in this study, but are important to a proportion of patients with end stage renal failure. There is significant potential for improved prevention and earlier conservative treatment to slow deterioration in renal function and affect the number of patients requiring RRT . A decision not to offer treatment may also be appropriate  although age alone may sometimes inappropriately be used as a criterion for withholding treatment. In one study, the decision to withhold dialysis increased at a rate of 12% for every 10 years of increasing age even after adjustment for conditions such as dementia and/or dependency .
Comparison with other studies
Most of the significant epidemiological work on renal disease in the UK has been undertaken by the UK Renal Registry  and its Scottish counterpart . The annual report of the UK Renal Registry in particular contains information submitted by all the renal units in Wales and has expanded year on year. The negative influence of geographical distance from a renal unit has also previously been demonstrated in Wales . In Scotland, the effect of social class , co-morbidity  and referral patterns of GPs and non-nephrologists  have been studied in detail. Co-morbidity and non-referral are often linked to age [21, 23] but the epidemiological consequences for very elderly patients has rarely been examined .
The study explores the importance of providing RRT rates for patients over 75 years to more accurately reflect the rapid changes in RRT provision that are occurring in this age group. The study identifies variation, and potential inequality, in the provision of RRT by age, gender and geographical location. The gender difference in haemodialysis rates in the very elderly is particularly marked and emphasises the value of calculating age and gender specific rates of RRT rather than using one combined age-standardised rate to represent all those over 75 years.
Significant numbers of very elderly patients who are currently not receiving RRT may wish to have this as the elderly population increases, and as technology improves survival and quality of life on RRT. The study also suggests that if technologies that are more effective were developed, which had a lower impact on quality of life, there might be up to a 17% increase in demand for RRT in those aged over 75 years, and given current patterns of treatment, around 90% of this increase in demand would be for haemodialysis.
We would like to acknowledge the support of a large number of renal physicians and data managers in different NHS Trusts in Wales and England. We would also like to acknowledge Health Commission Wales who commissioned the analysis in conjunction with the South Wales Renal Managed Clinical Network. No funding was provided to the authors of the study.
- Turner N: A brief history of dialysis and transplantation. 2004, Edinburgh , Royal Infirmary of EdinburghGoogle Scholar
- Kidney Alliance: End Stage Renal Failure - A Framework for Planning and Service Delivery. 2001, Woking , The Kidney Alliance, 1-22.Google Scholar
- Renal Association: A Vision for the Future of Renal Services. 2002, London , Renal Association, 1-13.Google Scholar
- Ansell D, Feest TG, Ahmed A, Roa R: The Renal Association UK Renal Registry Seventh Annual Report. 2004, Bristol , The UK Renal RegistryGoogle Scholar
- Roderick PJ, Ferris G, Feest TG: The provision of renal replacement therapy for adults in England and Wales: recent trends and future directions. QJM. 1998, 91 (8): 581-587. 10.1093/qjmed/91.8.581.View ArticlePubMedGoogle Scholar
- Feest TG, Rajamahesh J, Byrne C, Ahmad A, Ansell D, Burden R, Roderick PJ: Trends in adult renal replacement therapy in the UK: 1982-2002. QJM. 2005, England , 98 (1): 21-28. 10.1093/qjmed/hci007.Google Scholar
- Roderick P, Davies R, Jones C, Feest T, Smith S, Farrington K: Simulation model of renal replacement therapy: predicting future demand in England. Nephrol Dial Transplant. 2004, 19 (3): 692-701. 10.1093/ndt/gfg591.View ArticlePubMedGoogle Scholar
- Government Actuary's Department: National Population Projections 2000-based, Series PP2 No. 23. 2002, Norwich , HMSO, 1-11.Google Scholar
- Julious SA, Nicholl J, George S: Why do we continue to use standardized mortality ratios for small area comparisons?. J Public Health Med. 2001, 23 (1): 40-46. 10.1093/pubmed/23.1.40.View ArticlePubMedGoogle Scholar
- Eastern Region Public Health Observatory: Standardisation. Inphorm. 2005, Cambridge , Eastern Region Public Health Observatory, 6: 1-8.Google Scholar
- Anderson RN, Rosenburg HM: Age standardization of death rates: implementation the year 2000 standard, National Vital Statistics Reports vol. 47 no. 3. 1998, Hyattsville, MD , National Center for Health StatisticsGoogle Scholar
- Newcombe RG: Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med. 1998, ENGLAND , 17 (8): 857-872. 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E.Google Scholar
- Wilson EB: Probable inference, the law of succession, and statistical inference. J Am Stat Assoc. 1927, 22: 209-212. 10.2307/2276774.View ArticleGoogle Scholar
- Chandna SM, Schulz J, Lawrence C, Greenwood RN, Farrington K: Is there a rationale for rationing chronic dialysis? A hospital based cohort study of factors affecting survival and morbidity. BMJ. 1999, 318 (7178): 217-223.View ArticlePubMedPubMed CentralGoogle Scholar
- Mulkerrin EC: Rationing renal replacement therapy to older patients - agreed guidelines are needed. QJM. 2000, ENGLAND , 93 (4): 253-255. 10.1093/qjmed/93.4.253.Google Scholar
- Burgess E: Conservative treatment to slow deterioration of renal function: evidence-based recommendations. Kidney Int Suppl. 1999, UNITED STATES , 70: S17-25. 10.1046/j.1523-1755.1999.07003.x.Google Scholar
- Hamel MB, Teno JM, Goldman L, Lynn J, Davis RB, Galanos AN, Desbiens N, Connors AF, Wenger N, Phillips RS: Patient age and decisions to withhold life-sustaining treatments from seriously ill, hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. Ann Intern Med. 1999, UNITED STATES , 130 (2): 116-125.Google Scholar
- Scottish Renal Association: Scottish Renal Registry Report, 2001. 2003, Edinburgh , Information & Statistics Division, 1-52.Google Scholar
- Boyle PJ, Kudlac H, Williams AJ: Geographical variation in the referral of patients with chronic end stage renal failure for renal replacement therapy. QJM. 1996, ENGLAND , 89 (2): 151-157.Google Scholar
- Metcalfe W, MacLeod AM, Bennett D, Simpson K, Khan IH: Equity of renal replacement therapy utilization: a prospective population-based study. QJM. 1999, ENGLAND , 92 (11): 637-642. 10.1093/qjmed/92.11.637.Google Scholar
- Khan IH, Catto GR, Edward N, MacLeod AM: Chronic renal failure: factors influencing nephrology referral. QJM. 1994, ENGLAND , 87 (9): 559-564.Google Scholar
- Challah S, Wing AJ, Bauer R, Morris RW, Schroeder SA: Negative selection of patients for dialysis and transplantation in the United Kingdom. BMJ. 1984, ENGLAND , 288 (6424): 1119-1122.Google Scholar
- Feest TG, Mistry CD, Grimes DS, Mallick NP: Incidence of advanced chronic renal failure and the need for end stage renal replacement treatment. BMJ. 1990, ENGLAND , 301 (6757): 897-900.Google Scholar
- Williams AJ, Antao AJ: Referral of elderly patients with end-stage renal failure for renal replacement therapy. Q J Med. 1989, 72 (268): 749-756.PubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2369/8/1/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.